
This Slide: #34 of 94 |
Slide #34. Americas Bullion Royalty Corp. — Assets of Kudu Partners, L.P.
Acquirer:
Americas Bullion Royalty Corp. (AMB.CA)
Acquiree:
Assets of Kudu Partners, L.P.
Details:
Americas Bullion Royalty Corp. (TSX:AMB.CA) (the "Company" or "AMB") is pleased to announce it has entered into a binding letter of intent ("LOI") to acquire the securities portfolio (the "Portfolio") of Kudu Partners, L.P. ("Kudu") from Kudu, a private hedge fund, in exchange for AMB shares (the "Transaction"). The Portfolio, estimated to have a current market value of approximately $21 million, is composed of cash, marketable securities and certain illiquid securities.
Ambrilia Biopharma is a biopharmaceutical company engaged in the development and commercialization of diagnostics and therapeutic drugs.
Open the AMB.CA Page at The Online Investor »
|
Open the AMB.CA Page at The Online Investor (in a new window) »

![]() ![]() Get SEC Filing Alerts Get Dividend Alerts ![]() ![]() |
